期刊
CANCER BIOMARKERS
卷 18, 期 2, 页码 161-167出版社
IOS PRESS
DOI: 10.3233/CBM-160090
关键词
Squamous cell lung cancer; circulating tumor cells; prognostic marker
类别
BACKGROUND: Squamous cell carcinoma (SCC) of the lung represents 20-30% of non-small cell lung cancers (NSCLC) and is associated with a poor prognosis. OBJECTIVE: This study aims to investigate the presence of circulating tumor cells (CTCs) in squamous cell lung cancer patients and what its role might be in providing prognostic information. METHODS: Serial blood samples from 100 patients both before and after initiation of one cycle of standard chemotherapy were analyzed using CellSearch system. RESULTS: Of 105 patients enrolled, 100 were evaluable. >= 2 CTCs per 7.5 mL of blood were present in 29% of patients at baseline before chemotherapy, and 9% patients have more than 5 CTCs. Based on the current literature, the CTC measurements were dichotomized as 2-4 versus >= 5 CTCs. In the univariate analysis, CTC count >= 5 at baseline and CTC count >= 5 at both time points (before and after one cycle of chemotherapy) were significantly associated with a poor PFS and OS outcome. Both factors remained independent poor prognostic markers in the stepwise multivariate analysis. CONCLUSION: Our study indicate that the CTC count is a prognostic factor for PFS and OS outcomes in Chinese patients with locally advanced SCC of the lung.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据